Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Feb 28, 2025
- Accession no.
- 0001022079-25-000074
- Filed
- Feb 28, 2025
- Trade date
- Feb 26-27, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $91.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | Common Stock | FTax withholdingDisposed | −286 | $171.75 | −$49,120.5 | 39,559 | Direct | |
| Feb 27, 2025 | Common Stock | SSaleDisposed | −528 | $172.61 | −$91,138.08 | 39,031 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.